Attempts of targeting the trending tumor associated antigens PD-1 and PD-L1, have achieved great success in certain cancers, but made limited progress in other cancer settings including ovarian (Zhu et al., 2021) and pancreatic (Feng et al., 2017). This evidence concerns the gene CD274 and cancer.